High impact
Biomarker Testing Coverage Implemented Effective July 1, 2026
Mississippi Medicaid (DOM)·Effective Jan 1, 2027
HCPCS A9274 is officially defined as "External ambulatory insulin delivery system, disposable, each, includes all supplies and accessories." HCPCS A9274 is referenced in 1 tracked payer policy change from Mississippi Medicaid (DOM). For billers and coders, staying current on payer-specific coverage criteria, reimbursement rules, and prior-authorization requirements for HCPCS A9274 is critical to clean claim submission. Each entry below links to the full policy analysis with effective dates and action steps.
Related
Get alerts for changes like this
Save a search and receive a daily digest whenever a new policy change matches your filters.